| Title | Cancer Chemotherapy and Pharmacology |
| Abbreviation | Cancer Chemother. Pharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2) |
| h-index | 127 |
| Overall Rank/Ranking | 5089 |
| SCImago Journal Rank (SJR) | 0.969 |
| Impact Score | 2.70 |
| Publisher | Springer Science and Business Media Deutschland GmbH |
| Country | Germany |
| ISSN | 14320843, 03445704 |
| Best Quartile | Q1 |
| Coverage History | 1978-2025 |
Cancer Chemotherapy and Pharmacology is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2). It is published by Springer Science and Business Media Deutschland GmbH. The overall rank of Cancer Chemotherapy and Pharmacology is 5089. According to SCImago Journal Rank (SJR), this journal is ranked 0.969. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 127. The best quartile for this journal is Q1.
The ISSN of Cancer Chemotherapy and Pharmacology journal is 14320843, 03445704. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Chemotherapy and Pharmacology is cited by a total of 1145 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Cancer Chemotherapy and Pharmacology is 2.70, which is computed in 2025 as per its definition. Cancer Chemotherapy and Pharmacology IF is decreased by a factor of 0.03 and approximate percentage change is -1.1% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Cancer Chemotherapy and Pharmacology is 2.70. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.70 |
| 2023 | 2.73 |
| 2022 | 2.90 |
| 2021 | 3.25 |
| 2020 | 2.91 |
| 2019 | 3.05 |
| 2018 | 3.13 |
| 2017 | 2.94 |
| 2016 | 2.96 |
| 2015 | 3.26 |
| 2014 | 3.35 |
Cancer Chemotherapy and Pharmacology has an h-index of 127. It means 127 articles of this journal have more than 127 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Chemotherapy and Pharmacology is 14320843, 03445704. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Chemotherapy and Pharmacology is 5089. According to SCImago Journal Rank (SJR), this journal is ranked 0.969. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.969 |
| 2023 | 0.869 |
| 2022 | 0.811 |
| 2021 | 0.848 |
| 2020 | 1.112 |
| 2019 | 1.239 |
| 2018 | 1.199 |
| 2017 | 1.147 |
| 2016 | 1.204 |
| 2015 | 1.266 |
| 2014 | 1.141 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5089 |
| 2023 | 5508 |
| 2022 | 5848 |
| 2021 | 5256 |
| 2020 | 3725 |
| 2019 | 3082 |
| 2018 | 3322 |
| 2017 | 3583 |
| 2016 | 3342 |
| 2015 | 3138 |
| 2014 | 3575 |
Cancer Chemotherapy and Pharmacology is published by Springer Science and Business Media Deutschland GmbH. It's publishing house is located in Germany. Coverage history of this journal is as following: 1978-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Chemotherapy and Pharmacology is Cancer Chemother. Pharmacol.. This abbreviation ('Cancer Chemother. Pharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Chemotherapy and Pharmacology latest impact IF is 2.70. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.35 (2014) and 2.70 (2024), respectively, in the last 11 years. Moreover, its average IS is 3.02 in the previous 11 years.
The Cancer Chemotherapy and Pharmacology has an SJR (SCImago Journal Rank) of 0.969, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.266 in 2015 and the lowest being 0.811 in 2022. Furthermore, the average SJR of the Cancer Chemotherapy and Pharmacology over the previous 11-year period stands at 3.02.
The latest h-index of the Cancer Chemotherapy and Pharmacology is 127.
The Cancer Chemotherapy and Pharmacology is published by the Springer Science and Business Media Deutschland GmbH, with its country of publication being the Germany.
The Cancer Chemotherapy and Pharmacology is currently ranked 5089 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3082 in 2019 and its lowest position of 5848 in 2022.
The standard ISO4 abbreviation for the Cancer Chemotherapy and Pharmacology is Cancer Chemother. Pharmacol..
Cancer Chemotherapy and Pharmacology is classified as a journal that the Springer Science and Business Media Deutschland GmbH publishes.
The Cancer Chemotherapy and Pharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Chemotherapy and Pharmacology is assigned the following International Standard Serial Numbers (ISSN): 14320843, 03445704.
The best quartile for the Cancer Chemotherapy and Pharmacology is Q1 (2024).
The Cancer Chemotherapy and Pharmacology coverage history can be summarized as follows: 1978-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 9089 | Institute of Electrical and Electronics Engineers Inc. | 55 | 2.19 |
| Journal of Competition Law and Economics | journal | 11978 | Oxford University Press | 34 | 0.94 |
| International Journal of Mathematical Education in Science and Technology | journal | 6477 | Taylor and Francis Ltd. | 45 | 1.82 |
| Journal of Classical Sociology | journal | 16960 | SAGE Publications Ltd | 31 | 0.68 |
| Modern Language Journal | journal | 1033 | Wiley-Blackwell | 123 | 3.95 |
| Journal of Sociolinguistics | journal | 4415 | Wiley-Blackwell Publishing Ltd | 68 | 2.14 |
| Libyan Studies | journal | 21508 | Cambridge University Press | 10 | 0.14 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.70 |
| 2023 | 2.73 |
| 2022 | 2.90 |
| 2021 | 3.25 |
| 2020 | 2.91 |
| 2019 | 3.05 |
| 2018 | 3.13 |
| 2017 | 2.94 |
| 2016 | 2.96 |
| 2015 | 3.26 |
| 2014 | 3.35 |
